New Key Statistics Module, Z-Score and F-Score
SZSE:002275 Key Ratios
Market Cap ¥ M | 7,268.22 |
Enterprise Value ¥ M | 6,351.02 |
P/E(ttm) | 20.62 |
PE Ratio without NRI | 20.02 |
Forward PE Ratio | -- |
Price/Book | 2.50 |
Price/Sales | 3.76 |
Price/Free Cash Flow | 16.26 |
Price/Owner Earnings | 32.13 |
Payout Ratio % | 1.13 |
Revenue (TTM) ¥ M | 1,938.00 |
EPS (TTM) ¥ | 0.60 |
Beneish M-Score | -2.89 |
10-y EBITDA Growth Rate % | 0.80 |
5-y EBITDA Growth Rate % | 2.80 |
y-y EBITDA Growth Rate % | -18.70 |
EV-to-EBIT | 14.46 |
EV-to-EBITDA | 14.46 |
PEG | 7.15 |
Shares Outstanding M | 587.57 |
Net Margin (%) | 18.17 |
Operating Margin % | 21.76 |
Pre-tax Margin (%) | 22.22 |
Quick Ratio | 2.77 |
Current Ratio | 3.18 |
ROA % (ttm) | 9.04 |
ROE % (ttm) | 12.01 |
ROIC % (ttm) | 15.98 |
Dividend Yield % | 4.81 |
Altman Z-Score | 6.78 |
SZSE:002275 Number of Guru Trades
SZSE:002275 Volume of Guru Trades
Gurus Latest Trades with SZSE:002275
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002275 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guilin Sanjin Pharmaceutical Co Ltd Insider Transactions
No Available Data